0 likes | 14 Views
The pancreatic adenocarcinoma treatment market is estimated to occupy a large revenue by growing at a CAGR of ~14% during the forecast period, i.e., 2023 u2013 2035, owing to the rising prevalence of obesity, increasing geriatric population worldwide, and growing consumption of alcohol and smoking. Apart from these, rise in development of innovative treatments for pancreatic cancer is also expected to provide ample growth opportunities to the market.
E N D